Universal hepatitis B vaccination: the economics of prevention.

Por Krahn, M D, Detsky, A S
Publicado em 1992

Current and projected annual direct costs of screening asymptomatic men for prostate cancer using prostate-specific antigen

Por Krahn, M D, Coombs, A, Levy, I G
Publicado em 1999

Prostate cancer: 2. Natural history

Por Nam, R K, Jewett, M A, Krahn, M D
Publicado em 1998

Prostate cancer: 12. The economic burden

Por Grover, S A, Zowall, H, Coupal, L, Krahn, M D
Publicado em 1999

Direct and indirect costs of asthma in Canada, 1990.

Por Krahn, M D, Berka, C, Langlois, P, Detsky, A S
Publicado em 1996

Direct health-care costs attributed to hip fractures among seniors: a matched cohort study

Por Nikitovic, M., Wodchis, W. P., Krahn, M. D., Cadarette, S. M.
Publicado em 2012

Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events

Por Krahn, M.D., Bremner, K.E., Luo, J., Alibhai, S.M.H.
Publicado em 2014

A160 ESTIMATION OF FIBROSIS PROGRESSION RATES FOR CHRONIC HEPATITIS C: UPDATED META-ANALYSIS AND META-REGRESSION

Por Erman, A, Hansen, T, Bielecki, J M, Feld, J, Krahn, M D, Thein, R
Publicado no J Can Assoc Gastroenterol (2018)

Direct costs of coronary artery bypass grafting in patients aged 65 years or more and those under age 65

Por Naglie, G, Tansey, C, Krahn, M D, O'Rourke, K, Detsky, A S, Bolley, H
Publicado em 1999

Long-term health care costs for prostate cancer patients on androgen deprivation therapy

Por Krahn, M.D., Bremner, K.E., Luo, J., Tomlinson, G., Alibhai, S.M.H.
Publicado no Curr Oncol (2016)

Population-based trends in systemic therapy use and cost for cancer patients in the last year of life

Por Pataky, R.E., Cheung, W.Y., de Oliveira, C., Bremner, K.E., Chan, K.K.W., Hoch, J.S., Krahn, M.D., Peacock, S.J.
Publicado no Curr Oncol (2016)